Levothyroxine Sodium Injection, Powder, Lyophilized, For Solution
Product Images NDC 42023-201

8 FDA label images from Endo Usa, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 42023-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Endo Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Levot-struc-01.jpg (Levot Struc 01)

Levot-struc-01.jpg (Levot Struc 01)
Chemical structure of Levothyroxine Sodium, showing its molecular configuration with iodinated phenyl rings and an amino acid side chain.*
FDA Label Image

Levot-img-01.jpg (Levot Img 01)

FDA Label Image

Levot-label-01.jpg (Levot Label 01)

Levot-label-01.jpg (Levot Label 01)
Label for Levothyroxine Sodium Injection, 100 mcg per vial, lyophilized powder for intravenous use from ENDO USA, Inc. The label includes instructions for reconstitution, storage conditions, and states it is a single-dose vial for prescription use only. The label features a barcode and lot/expiration information.*
FDA Label Image

Levot-label-02.jpg (Levot Label 02)

Levot-label-02.jpg (Levot Label 02)
Label of Levothyroxine Sodium injection, powder, lyophilized for solution, showing 100 mcg per vial strength. The label is marked for intravenous use and single dose vial, manufactured for Endo USA, Inc. It includes storage instructions at 20° to 25°C, reconstitution directions, and notes that the container closure does not contain natural rubber latex.*
FDA Label Image

Levot-label-03.jpg (Levot Label 03)

Levot-label-03.jpg (Levot Label 03)
Levothyroxine Sodium injection label for a single-dose vial containing 500 mcg per vial of lyophilized powder for intravenous use. The label includes handling instructions, storage conditions (20°C to 25°C), and states the product is preservative-free and sterile. It is manufactured by ENDO USA, Inc., Malvern, PA. The barcode and lot/expiration information are also shown.*
FDA Label Image

Levot-label-04.jpg (Levot Label 04)

Levot-label-04.jpg (Levot Label 04)
Levothyroxine Sodium 500 mcg per vial injection label for lyophilized powder for solution. Sterile, preservative free. Manufactured by Endo USA, Inc. Includes reconstitution directions, storage instructions (20° to 25°C), and notes that the vial is single-dose for intravenous use. Label displays NDC 42023-203-01 and barcode.*
FDA Label Image

Levot-label-05.jpg (Levot Label 05)

Levot-label-05.jpg (Levot Label 05)
Label for Levothyroxine Sodium for Injection 200 mcg per vial, a lyophilized powder for intravenous use. The single-dose vial is sterile, preservative-free, and manufactured by Endo USA, Inc. The label includes storage instructions, preparation directions, and a barcode with NDC 42023-202-01.*
FDA Label Image

Levot-label-06.jpg (Levot Label 06)

Levot-label-06.jpg (Levot Label 06)
Label for Levothyroxine Sodium Injection, 200 mcg per vial, lyophilized powder for intravenous use. The label notes a preservative-free, sterile product, with instructions for reconstitution using 5 mL of 0.9% Sodium Chloride Injection. It includes storage information, manufacturer Endo USA, Inc., and a barcode. The vial is single dose with disposal instructions for unused portions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.